Clinical trials
Completed Carcinoma, Transitional Cell trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
30 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2007 | 1 |
| 2008 | 2 |
| 2011 | 3 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 4 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 5 |
| 2020 | 2 |
| 2021 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 30 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bristol-Myers Squibb | 3 |
| Incyte Corporation | 3 |
| Bayer | 2 |
| Eli Lilly and Company | 2 |
| Nektar Therapeutics | 2 |
| Pfizer | 2 |
| Achieve Life Sciences | 1 |
| Acrotech Biopharma Inc. | 1 |
| Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie | 1 |
| Astellas Pharma Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Transitional Cell | 30 |
| Urinary Bladder Neoplasms | 19 |
| Neoplasm Metastasis | 6 |
| Carcinoma, Non-Small-Cell Lung | 5 |
| Urologic Neoplasms | 4 |
| Ureteral Neoplasms | 3 |
| Urethral Neoplasms | 3 |
| Acrocephalosyndactylia | 2 |
| Breast Neoplasms | 2 |
| Carcinoma, Hepatocellular | 2 |
Trials
Showing 1 to 25 of 30. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.